GFJ ESG Acquisition I SE

  • ISIN: LU2358378979

Nachricht vom 22.10.2021 | 21:35

GFJ ESG Acquisition I SE: Notification of Home Member State

GFJ ESG Acquisition I SE / Home Member State
22.10.2021 / 21:35
Dissemination of a Post-admission Duties announcement transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

Following the issuance of shares admitted to trading in Germany on 18 October 2021, GFJ ESG Acquisition I SE, a société européenne incorporated and existing under the laws of the Grand Duchy of Luxembourg, with registered office at 55, Avenue Pasteur, L-2311 Luxembourg, Grand Duchy of Luxembourg and registered with the Luxembourg Trade and Companies Register under number B255487 and bearing LEI number 391200CLINOY60KP3T33, has chosen LUXEMBOURG as its home Member State for purposes of the application of the Luxembourg law of 11 January 2008 on transparency requirements regarding information about issuers whose securities are admitted to trading on a regulated market, as amended (the Transparency Law). The Commission de surveillance du secteur financier in Luxembourg has been notified in respect of the home Member State election on 22 October 2021.


22.10.2021 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de



show this

GBC im Fokus

IGEA Pharma N.V. Realignment to CBD extraction

The goal is to become the quality and cost leader in the field of CBD in Europe. To this end, a GMP pharma compliant plant is being built in Switzerland. The supercritical CO2 extraction process is to be used to achieve the highest standard of quality. The CBD market is growing strongly and with the focus on quality leadership and pure extraction, IGEA Pharma's new business model should be able to occupy an attractive niche market. With the proprietary supercritical CO2-extraction technology, other markets such as vanilla, rose or rosemary can be developed in the medium term. Based on our DCF model, we have determined a fair value of € 1.05 (CHF 1.13) per share and assign a BUY rating.

News im Fokus

Infineon Technologies AG: Aufsichtsrat beruft Jochen Hanebeck zum Nachfolger von Dr. Reinhard Ploss als Vorstandsvorsitzenden von Infineon

25. November 2021, 17:45

Aktuelle Research-Studie

3U HOLDING AG

Original-Research: 3U HOLDING AG (von GSC Research GmbH): Halten

26. November 2021